E-Mail
IMAGE: Yale researchers and collaborators have devised a strategy that allows them to see this previously impenetrable process unfold in a living animal the worm Caenorhabditis elegans, they report February. view more
Credit: The work is the result of a decade long collaboration between the labs of Colón-Ramos and Smita Krishnaswamy of Yale; Hari Shroff of the National Institutes of Health; Zhirong Bao.
The formation of a brain is one of nature s most staggeringly complex accomplishments. The intricate intermingling of neurons and a labyrinth of connections also make it a particularly difficult feat for scientists to study.
Southern Maine Health Care welcomes Dr. Uche Onuoha
Staff Report
BIDDEFORD, Maine – Southern Maine Health Care (SMHC) welcomes Uche Onuoha, MD, MPH who will serve as the Medical Director for WorkWell, Southern Maine Health Care’s Occupational Health Program.
Dr. Onuoha completed an internship in Internal Medicine at Albert Einstein Medical Center in Philadelphia, followed by Occupational and Environmental Medicine at the University of Connecticut Health Center and Mount Sinai School of Medicine in New York, respectively. Dr. Onuoha is a graduate of the University of Pennsylvania and received her Doctorate at Temple University School of Medicine, both in Philadelphia. She also holds a Master of Public Health from Mount Sinai School of Medical, New York. Since completing her training 9 years ago, Dr. Onuoha has practiced Occupational and Environmental medicine in large hospital based networks in New York and Pennsylvania.
A new study by researchers at the University of Connecticut Health Center, USA, reports the crucial nature of the pathogen pattern recognition receptor (PRRs), especially the two RLRs, retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated protein 5 (MDA5), in triggering host cell immune responses within the cell. The RLRs are viral RNA sensors.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Dong Yu, Ph.D., Joins Dynavax as Senior Vice President of Vaccine Research
February 8, 2021 GMT
EMERYVILLE, Calif., Feb. 8, 2021 /PRNewswire/ Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that Dong Yu, Ph.D., has joined the Company as Senior Vice President of Vaccine Research and a member of the Executive Team. Dr. Yu will drive Dynavax’s vaccine programs and technology platforms, building and maintaining a pipeline for long-term company growth.
ADVERTISEMENT
“We are extremely fortunate to welcome Dong to the Dynavax team as we continue to build a leading global vaccine company,” commented Ryan Spencer, Chief Executive Officer of Dynavax. “Dong is a well-respected scientist with over 15 years of experience and a remarkable track-record of identifying and progressing vaccine researc
Gov. Ned Lamont assigned $40 million of Connecticut’s emergency pandemic relief from Washington, D.C., on Thursday to aid hospitals a move that drew praise from the industry, yet one that was far less than hospitals sought.